Royal Bank Of Canada Journey Medical Corp Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Journey Medical Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 250 shares of DERM stock, worth $1,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 371
32.61%
Holding current value
$1,014
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DERM
# of Institutions
39Shares Held
2.93MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$3.51 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.32 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.28 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.09 Million0.0% of portfolio
-
American Financial Group Inc180KShares$730,7990.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $47.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...